Subtilitas

Subtilitas is a medical technology company specializing in advanced imaging software for the early detection and management of osteoporosis. The company's flagship platform, Subtilitas DX, utilizes proprietary algorithms to analyze standard clinical X-rays, providing high-resolution assessments of bone micro-architecture and density. This technology enables clinicians to identify patients at high risk of fracture using existing imaging infrastructure, bypassing the need for specialized DXA scans in some contexts. By integrating seamlessly into clinical workflows, Subtilitas aims to improve diagnostic accuracy and facilitate earlier intervention for bone-related conditions. The company is a spin-out from the University of Cambridge and leverages decades of clinical research in cortical bone mapping.